The FDA strikes again... in matters of misleading claims

By Michelle Yeomans

- Last updated on GMT

Two more cosmetic brands have been rapped by the FDA for violating its regulation laws, bringing the number of companies to be pulled up on the matter in recent weeks to four.


What do you make of the FDA clamping down on cosmetic companies on this matter?

  • The FDA are being too harsh on the 'misleading claims' subject

  • The FDA are not being harsh enough

  • It doesn't concern me either way


Related topics: Regulation & Safety, Skin Care

Related news

Show more

Related products

show more

The first Exposome-Proof Natural Skin Brightener

The first Exposome-Proof Natural Skin Brightener

Symrise | 20-Oct-2017 | Product Brochure

Time has come to take a new look on pigmentation disorders. UV has long been identified as the main cause for aging and darks spots. But recent research...

SymDiol® 68 a smart synergistic protectant

SymDiol® 68 a smart synergistic protectant

Symrise | 09-Oct-2017 | Product Brochure

Today, cosmetic formulators face an increasingly challenging task to protect formulations and at the same time answering consumers’ desires for less preservatives...


Neossance® Squalane, Skin Therapy Benefits

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Sep-2017 | Clinical Study

Aprinnova is leading a resurgence in Squalane, reducing supply fears while making it attractive to use in mass/value positioned brands. Aprinnova is addressing...

Related suppliers